A trusted layer of defense
InspireMD (inspiremd.com) earns a Brand Analyzer score of 67 out of 100, placing it in the Developing tier among Healthcare brands. Among 2305 Healthcare brands analyzed, InspireMD ranks in the 43rd percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 88/100, Digital Presence 82/100, Visual Identity 88/100, Messaging Clarity 95/100, Trust Foundation 64/100, AI Discoverability 76/100, Brand Authority 13/100.
InspireMD is a medical technology company founded in 2013, focused on innovative solutions for vascular disease treatment. The company develops the CGuard® Embolic Prevention System, a dual-layered stent designed to provide mechanical scaffolding and embolic protection, reducing stroke risk during carotid revascularization. InspireMD positions itself as a leader in advanced embolic protection technology for high-risk vascular procedures, targeting interventional cardiologists, vascular surgeons, and hospitals.
| Brand Name | InspireMD |
|---|---|
| Domain | inspiremd.com |
| Industry | Healthcare |
| Founded | 2013 |
| Main Competitors | Abbott (91/100), Boston Scientific (80/100), Medtronic (83/100), Cordis, Silk Road Medical |
Moz Domain Authority 39/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,336,159 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "InspireMD is a medical technology company focused on innovative solutions for the treatment of vascular disease, advancing embolic protection to improve patient outcomes." (Meta description: 23 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:type, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, YouTube, Facebook, Instagram, GitHub; no detected presence on X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
InspireMD scores 34/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
InspireMD has a weak AI-visibility profile at 34/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (58/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,336,159 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 39/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
InspireMD's primary product is the CGuard® Embolic Prevention System, a dual-layered stent used in carotid revascularization procedures. The device is designed to provide both mechanical scaffolding to keep the artery open and embolic protection to capture and contain debris that could otherwise travel to the brain and cause a stroke. It is intended for patients at high risk for adverse events from carotid endarterectomy.
Sources: InspireMD official site
InspireMD's main competitors include Abbott (91/100), Boston Scientific (80/100), Medtronic (83/100), Cordis, Silk Road Medical. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: InspireMD official site
InspireMD and Abbott are competitors in Healthcare. Brand Analyzer scores InspireMD at 67/100 and Abbott at 91/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: InspireMD official site
InspireMD is a medical technology company focused on innovative solutions for the treatment of vascular disease. Founded in 2013, the company specializes in advancing embolic protection technologies aimed at improving patient outcomes during vascular procedures. It positions itself as a leader in advanced embolic protection technology for high-risk vascular procedures, serving interventional cardiologists, vascular surgeons, and hospitals.
Sources: InspireMD official site
InspireMD develops medical devices for the treatment of vascular disease, with a particular emphasis on advancing embolic protection. The company's primary focus is on carotid revascularization procedures, where it works to reduce the risk of stroke. It develops products that combine mechanical scaffolding with embolic protection to address the needs of patients at high risk for adverse events during carotid procedures.
Sources: InspireMD official site
Popular alternatives to InspireMD include Abbott (91/100), Boston Scientific (80/100), Medtronic (83/100), Cordis, Silk Road Medical. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: InspireMD official site
InspireMD has limited AI-search visibility, scoring 34/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 33, recommendation 58). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: InspireMD official site
InspireMD is known for developing the CGuard® Embolic Prevention System, a dual-layered stent designed for carotid revascularization. The device provides both mechanical scaffolding and embolic protection, aimed at reducing stroke risk during the procedure. InspireMD is also recognized for its positioning as a leader in advanced embolic protection technology for high-risk vascular procedures.
Sources: InspireMD official site
InspireMD was founded in 2013. InspireMD operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
InspireMD's products and solutions are used by interventional cardiologists, vascular surgeons, and hospitals that treat patients requiring carotid revascularization. Specifically, the target users are medical professionals and facilities treating patients considered at high risk for adverse events from carotid endarterectomy, a surgical procedure to remove plaque from the carotid artery.
Sources: InspireMD official site
InspireMD scores 58/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: InspireMD official site
InspireMD can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: InspireMD official site
Ranked closest to InspireMD: Innomar Strategies (67/100), infologiQ (67/100), Intiva Health (67/100), Iris Telehealth (67/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).